Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | SI | P14410 | 1/20 | 0.33 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.33 |
| ▸ | CCR5 | P51681 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14085933 | 1.00 | MGAM (0.33) | MGAMGAASIMGAM2CCR5 | |
| SCHEMBL5750982 | 1.00 | MGAM (0.33) | MGAMGAASIMGAM2CCR5 | |
| SCHEMBL13127200 | 0.87 | — | — | |
| Acetic Acid SCHEMBL34474209 | 0.85 | CHRNB2 (0.35) | MGAMGAASIMGAM2 | |
| SCHEMBL18436931 | 0.84 | — | — | |
| SCHEMBL15488925 | 0.84 | — | — | |
| SCHEMBL293407 | 0.83 | GLB1 (0.39) | MGAMGAASIMGAM2 | |
| SCHEMBL16661382 | 0.82 | — | — | |
| SCHEMBL25774805 | 0.82 | ALDH1A1 (0.32) | — | |
| SCHEMBL292784 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260092138-A1 | BLOCKED POLYISOCYANATE COMPOSITION, CURABLE RESIN COMPOSITION COMPRISING THE COMPOSITION, AND CURED PRODUCT | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2026-04-02 | — | — | US | disclosed |
| EP-4703326-A1 | METHOD FOR RECOVERING ALKALI METAL SALT AND APPARATUS FOR RECOVERING ALKALI METAL SALT | Toray Industries, Inc. (JP) | 2026-03-04 | — | — | EP | disclosed |
| EP-4628199-A1 | COMPOSITE SEMIPERMEABLE MEMBRANE, COMPOSITE SEMIPERMEABLE MEMBRANE ELEMENT, AND FILTER DEVICE | Toray Industries, Inc. (JP) | 2025-10-08 | — | — | EP | disclosed |
| EP-4628609-A1 | METHOD FOR RECOVERING ALKALI METAL SALT AND APPARATUS FOR RECOVERING ALKALI METAL SALT | Toray Industries, Inc. (JP) | 2025-10-08 | — | — | EP | disclosed |
| WO-2025070624-A1 | METHOD AND DEVICE FOR RECOVERING ALKALI METAL IONS AND HYDROXIDE IONS | 東レ株式会社 | 2025-04-03 | — | — | WO | disclosed |
| WO-2024225409-A1 | METHOD FOR RECOVERING ALKALI METAL SALT AND APPARATUS FOR RECOVERING ALKALI METAL SALT | 東レ株式会社 | 2024-10-31 | — | — | WO | disclosed |
| US-20240247088-A1 | DISPERSANT FOR POWER STORAGE DEVICE POSITIVE ELECTRODE | KAO CORPORATION (JP) | 2024-07-25 | — | — | US | disclosed |
| WO-2024117238-A1 | COMPOSITE SEMIPERMEABLE MEMBRANE, COMPOSITE SEMIPERMEABLE MEMBRANE ELEMENT, AND FILTER DEVICE | 東レ株式会社 | 2024-06-06 | — | — | WO | disclosed |
| WO-2024117236-A1 | METHOD FOR RECOVERING ALKALI METAL SALT AND APPARATUS FOR RECOVERING ALKALI METAL SALT | 東レ株式会社 | 2024-06-06 | — | — | WO | disclosed |
| EP-4336596-A1 | DISPERSANT FOR POWER STORAGE DEVICE POSITIVE ELECTRODE | Kao Corporation (JP) | 2024-03-13 | — | — | EP | disclosed |
| EP-2287162-A1 | Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disorders | Otsuka Pharmaceutical Co., Ltd. (JP) | 2011-02-23 | — | — | EP | disclosed |
| EP-2287161-A1 | Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disorders | Otsuka Pharmaceutical Co., Limited (JP) | 2011-02-23 | — | — | EP | disclosed |
| EP-2284169-A1 | Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of CNS disorders | Otsuka Pharmaceutical Co., Limited (JP) | 2011-02-16 | — | — | EP | disclosed |
| US-20100317568-A1 | Anti-Viral Compounds | Abbott Labaoratories (US) | 2010-12-16 | — | — | US | disclosed |
| US-20100197703-A1 | N-SULFONYL THIAZOLYLPIPERAZINE DERIVATIVES AND RELATED N-SULFONYL HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF NEURO DEGENERATIVE DISEASES | NV REMYND (BE) | 2010-08-05 | — | — | US | disclosed |
| US-20090264404-A1 | Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disorders | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2009-10-22 | — | — | US | disclosed |
| US-7414057-B2 | Piperazine urea derivatives as melanocortin-4 receptor agonists | MERCK & CO., INC. (US) | 2008-08-19 | — | — | US | disclosed |
| US-7414057-B2 | Piperazine urea derivatives as melanocortin-4 receptor agonists | MERCK & CO., INC. (US) | 2008-08-19 | — | — | US | disclosed |
| US-4837324-A | Process for the reaction of piperazine, and derivatives thereof, with glyoxal, and derivatives thereof | THE DOW CHEMICAL COMPANY (US) | 1989-06-06 | — | — | US | disclosed |
| US-4761476-A | Compounds formed by the reaction of piperazine, and derivatives thereof, with glyoxal, and derivatives thereof | THE DOW CHEMICAL COMPANY (US) | 1988-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100317568-A1 | Anti-Viral Compounds | HAVCR2, EIF2AK2, MAVS | MGAM 2749/4885GAA 223/4885SI 3674/4885 |
| US-20100197703-A1 | N-SULFONYL THIAZOLYLPIPERAZINE DERIVATIVES AND RELATED N-SULFONYL HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF NEURO DEGENERATIVE DISEASES | SMN1; SMN2, HTT, SNCA | MGAM 3724/4885GAA 110/4885SI 1100/4885 |
| US-20260092138-A1 | BLOCKED POLYISOCYANATE COMPOSITION, CURABLE RESIN COMPOSITION COMPRISING THE COMPOSITION, AND CURED PRODUCT | RER1, RPP30, REV1 | MGAM 2823/4885GAA 3726/4885SI 2401/4885 |
| US-20090264404-A1 | Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disorders | GRIN2C, GRIN2B, PMP22 | MGAM 4151/4885GAA 3355/4885SI 4578/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.